Published in Immunotherapy Weekly, May 14th, 2000
Now, at a recent conference, researchers at Johns Hopkins University, the University of California at San Diego, and Dynavax Technologies Corporation announced that they have developed a method of modifying an allergen, such as ragweed, to create a vaccine that may solve many of these concerns.
"Our first experience of testing this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.